Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Organ Dysfunction/Mortality by BioAegis Therapeutics for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Organ Dysfunction/Mortality is under clinical development by BioAegis Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Pneumonia....
Data Insights
Organ Dysfunction/Mortality by BioAegis Therapeutics for Sepsis: Likelihood of Approval
Organ Dysfunction/Mortality is under clinical development by BioAegis Therapeutics and currently in Phase II for Sepsis. According to GlobalData, Phase...